Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated January 17, 2025, titled "Press Release for receipt of USFDA Approval".
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated January 17, 2025, titled "Press Release for receipt of USFDA Approval".